Region:Middle East
Author(s):Geetanshi
Product Code:KRAA0631
Pages:83
Published On:January 2026

By Type:The market is segmented into various types of diagnostic devices, each catering to specific healthcare needs. The subsegments include Blood Glucose Monitoring Devices, Infectious Disease Testing Kits, Cardiac Markers Testing Devices, Coagulation Testing Devices, Pregnancy and Fertility Testing Kits, and Others. Among these, Blood Glucose Monitoring Devices are leading the market due to the rising incidence of diabetes and the growing awareness of self-monitoring among patients.

By End-User:The end-user segmentation includes Hospitals, Clinics, Home Care Settings, Emergency Medical Services, and Others. Hospitals are the dominant end-user segment, driven by the increasing adoption of POC diagnostics for rapid patient assessment and management, particularly in emergency and critical care settings.

The Saudi Arabia Point of Care POC Diagnostics Market is characterized by a dynamic mix of regional and international players. Leading participants such as Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Becton, Dickinson and Company, Cepheid, Alere Inc., Bio-Rad Laboratories, Ortho Clinical Diagnostics, Quidel Corporation, Hologic, Inc., Thermo Fisher Scientific, Medtronic, Sysmex Corporation, Mindray Medical International Limited, Nova Biomedical contribute to innovation, geographic expansion, and service delivery in this space.
The future of the POC diagnostics market in Saudi Arabia appears promising, driven by increasing healthcare investments and a focus on enhancing patient care. The integration of artificial intelligence in diagnostic processes is expected to streamline operations and improve accuracy. Additionally, the expansion of telemedicine services will facilitate remote patient monitoring, further driving the demand for POC testing solutions. As healthcare providers adapt to these trends, the market is likely to witness significant growth and innovation in the coming years.
| Segment | Sub-Segments |
|---|---|
| By Type | Blood Glucose Monitoring Devices Infectious Disease Testing Kits Cardiac Markers Testing Devices Coagulation Testing Devices Pregnancy and Fertility Testing Kits Others |
| By End-User | Hospitals Clinics Home Care Settings Emergency Medical Services Others |
| By Application | Disease Diagnosis Health Monitoring Screening Others |
| By Distribution Channel | Direct Sales Online Sales Retail Pharmacies Others |
| By Technology | Lateral Flow Assays Microfluidics Molecular Diagnostics Others |
| By Region | Central Region Eastern Region Western Region Southern Region |
| By Policy Support | Government Subsidies Tax Incentives Research Grants Others |
| Scope Item/Segment | Sample Size | Target Respondent Profiles |
|---|---|---|
| Hospital Laboratories | 100 | Laboratory Managers, Clinical Pathologists |
| Primary Care Clinics | 80 | General Practitioners, Nurse Practitioners |
| Diagnostic Device Distributors | 60 | Sales Managers, Product Specialists |
| Public Health Officials | 50 | Health Policy Advisors, Epidemiologists |
| Patient Focus Groups | 8 | Chronic Disease Patients, Caregivers |
The Saudi Arabia Point of Care Diagnostics Market is valued at approximately USD 490 million, reflecting a significant growth driven by the increasing prevalence of chronic diseases and the demand for rapid diagnostic tests.